🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

🚨 BREAKING: Nike just introduced their Olympic commercial and slogan "Winning isn't for everyone" This is a masterclass in marketing for so many reasons Goosebumps:

Mesdames et messieurs, la Cérémonie d’ouverture de #Paris2024 Ladies and gentlemen, the Paris 2024 Opening Ceremony. 📸 Getty / Lionel Bonaventure

Replacing my right hand with AI (How I wrote thousands of lines of code for work each week while in a cast) erikschluntz.com/software/2024/…

Eric Schmidt says in the next year, AI models will unite three key pillars: very large context windows, agents and text-to-action, and no-one understands what the impact will be but it will involve everyone having a fleet of AI agents at their command

🧬 Excited for #ECP2024 in Florence! 🇮🇹 Join us at Booth L157 to discover SeqOne's innovative Oncology solutions. Learn about SomaHRD, SomaLBx, and SomaDNA for precision testing in cancer care. Plus, get a sneak peek at our upcoming SomaCGP. Let’s connect! 🔍✨ European Society of Pathology (ESP)

💻🍏 Apple’s Microchip under a microscope is mind blowing! 🤯

The Mamba Mentality - Kobe Bryant ‼️

Advancements in Next-Generation Sequencing are revolutionizing diagnostics in rare diseases. Discover how NGS brings hope and precision to treatment in our latest Genomic Insights piece. eu1.hubs.ly/H0c76pv0 #Genomics #RareDiseases #NGS

x.com/i/article/1836…

We are excited to partner with Platomics to offer genetic testing laboratories a flexible and robust solution for IVDR compliance. With this partnership, we can provide labs with additional options and tools they need to navigate the complex regulatory landscape while

Every day I strive to get closer to Apple's marketing philosophy:

Moment historique #SpaceX

Sharpen your focus by Frank Slootman, former CEO of Snowflake.

obsession over everything.

🎯 Proud to announce that the SeqOne Platform has achieved IVDR certification as a Class C medical device! 🚀 This landmark certification from GMED marks a crucial milestone in our mission to advance precision medicine through trusted genomic analysis. As one of the first

Snowflake CEO Frank Slootman telling the hard truths.

Failing to try is the only real failure.

Après tant d'années, ce tweet dont on a tant rêvé : CHAMPIONS D'EUROPE !! 🏆❤️💙

We're taking a big step towards medical superintelligence. AI models have aced multiple choice medical exams – but real patients don’t come with ABC answer options. Now MAI-DxO can solve some of the world’s toughest open-ended cases with higher accuracy and lower costs.